Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pete Lambert

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
PLOS Global Public Health|February 27, 2024
The quality of medicines for the prevention and management of hypertensive disorders of pregnancy: A systematic reviewPooja Maharjan, Meghna Prasannan Ponganam, Pete Lambert, et al.
Research in Social & Administrative Pharmacy : RSAP|August 4, 2019
Qualitative formative implementation research to inform introduction of a new essential medicineVictoria L Oliver, Moti Tolera, Alula M Teklu, et al.
Drug Discovery Today|November 7, 2022
Drug repurposing using real-world dataGeorge S Q Tan, Erica K Sloan, Pete Lambert, et al.
BMJ Open|October 27, 2018
Assessing the operational feasibility and acceptability of an inhalable formulation of oxytocin for improving community-based prevention of postpartum haemorrhage in Myanmar: a qualitative inquiryKyu Kyu Than, Victoria Oliver, Yasmin Mohamed, et al.
British Journal of Clinical Pharmacology|June 18, 2024
Application of immunocapture and nanoflow LC-MS/MS to overcome the barriers to the quantitation of oxytocin in plasma of women in third stage labourSebastiaan Bijttebier, Tri-Hung Nguyen, Michelle P McIntosh, et al.
British Journal of Clinical Pharmacology|April 4, 2026
A phase 1 evaluation of inhaled oxytocin: Physiologically-based pharmacokinetic model informed dosing of a novel heat-stable oxytocin delivery systemPete Lambert, Carl M J Kirkpatrick, Rory Marriott, et al.
Expert Review of Clinical Pharmacology|January 8, 2025
Closing the gaps in the access to quality-assured medicines for global health: The case for oxytocin for postpartum haemorrhageC C Lee, Luther Gwaza, Karin Rombouts, et al.
BMC Medicine|July 29, 2020
Cost-effectiveness of inhaled oxytocin for prevention of postpartum haemorrhage: a modelling study applied to two high burden settingsNatalie Carvalho, Mohammad Enamul Hoque, Victoria L Oliver, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 20, 2023
The compatibility of oxytocin and tranexamic acid injection products when mixed for co-administration by infusion for the treatment of postpartum haemorrhage: An in vitro investigationPete Lambert, Alessandra Tomazzini, Philip Wright, et al.
British Journal of Clinical Pharmacology|July 31, 2023
Exploring the role of ex vivo metabolism on blood and plasma measurements of oxytocin among women in the third stage of labour: A post hoc studyVictoria L Oliver, Sarah Siederer, Anthony Cahn, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
PLOS Global Public Health|February 27, 2024
The quality of medicines for the prevention and management of hypertensive disorders of pregnancy: A systematic reviewPooja Maharjan, Meghna Prasannan Ponganam, Pete Lambert, et al.
Research in Social & Administrative Pharmacy : RSAP|August 4, 2019
Qualitative formative implementation research to inform introduction of a new essential medicineVictoria L Oliver, Moti Tolera, Alula M Teklu, et al.
Drug Discovery Today|November 7, 2022
Drug repurposing using real-world dataGeorge S Q Tan, Erica K Sloan, Pete Lambert, et al.
BMJ Open|October 27, 2018
Assessing the operational feasibility and acceptability of an inhalable formulation of oxytocin for improving community-based prevention of postpartum haemorrhage in Myanmar: a qualitative inquiryKyu Kyu Than, Victoria Oliver, Yasmin Mohamed, et al.
British Journal of Clinical Pharmacology|June 18, 2024
Application of immunocapture and nanoflow LC-MS/MS to overcome the barriers to the quantitation of oxytocin in plasma of women in third stage labourSebastiaan Bijttebier, Tri-Hung Nguyen, Michelle P McIntosh, et al.
British Journal of Clinical Pharmacology|April 4, 2026
A phase 1 evaluation of inhaled oxytocin: Physiologically-based pharmacokinetic model informed dosing of a novel heat-stable oxytocin delivery systemPete Lambert, Carl M J Kirkpatrick, Rory Marriott, et al.
Expert Review of Clinical Pharmacology|January 8, 2025
Closing the gaps in the access to quality-assured medicines for global health: The case for oxytocin for postpartum haemorrhageC C Lee, Luther Gwaza, Karin Rombouts, et al.
BMC Medicine|July 29, 2020
Cost-effectiveness of inhaled oxytocin for prevention of postpartum haemorrhage: a modelling study applied to two high burden settingsNatalie Carvalho, Mohammad Enamul Hoque, Victoria L Oliver, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 20, 2023
The compatibility of oxytocin and tranexamic acid injection products when mixed for co-administration by infusion for the treatment of postpartum haemorrhage: An in vitro investigationPete Lambert, Alessandra Tomazzini, Philip Wright, et al.
British Journal of Clinical Pharmacology|July 31, 2023
Exploring the role of ex vivo metabolism on blood and plasma measurements of oxytocin among women in the third stage of labour: A post hoc studyVictoria L Oliver, Sarah Siederer, Anthony Cahn, et al.
Pageof 2